Reuters logo
3 months ago
BRIEF-Vericel enters into license agreement with Innovative Cellular Therapeutics
May 10, 2017 / 11:14 AM / 3 months ago

BRIEF-Vericel enters into license agreement with Innovative Cellular Therapeutics

1 Min Read

May 10 (Reuters) - Vericel Corp

* Vericel Corp - entered into a license agreement with Innovative Cellular Therapeutics for development, manufacturing and commercialization of Vericel product portfolio

* VERICEL - ICT will acquire exclusive rights to develop and distribute carticel, maci, ixmyelocel-t, and epicel in Greater China, South Korea, Singapore, and other countries in region

* Says under terms of license agreement, Vericel will receive an upfront payment of $6.0 million

* Says in addition, Vericel is eligible to receive about $8.0 million in development and commercial milestones Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below